TAMARA CHEATER: Open Payments
NPI 1760869382 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,654 in 93 payments from 13 companies in 2025. Trend: 2023 $496 · 2024 $1,123 · 2025 $2,654
Food & beverage: $1,782Consulting: $800Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $1,420 |
| Janssen Biotech, Inc. | 15 | $250 |
| Regeneron Healthcare Solutions, Inc. | 8 | $207 |
| UCB, Inc. | 4 | $197 |
| Amgen Inc. | 12 | $177 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| GENZYME CORPORATION | 3 | $81 |
| Lilly USA, LLC | 4 | $59 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| PFIZER INC. | 1 | $34 |
Products named: RINVOQ, DUPIXENT, TREMFYA, Bimzelx, OTEZLA, SKYRIZI, COSENTYX, Zoryve.
Industry payments across VA — which companies pay providers there.
